ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

BIOR Biora Therapeutics Inc

0,7003
-0,037 (-5,02%)
17 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Biora Therapeutics Inc BIOR NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,037 -5,02% 0,7003 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,74 0,7001 0,75 0,7297 0,7373
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202417:05GLOBEBiora Therapeutics Provides Corporate Update..
07/05/202409:00GLOBEBiora Therapeutics to Report First Quarter 2024 Financial..
06/05/202409:00GLOBEBiora Therapeutics to Present Clinical Data on Device..
30/04/202409:00GLOBEBiora Therapeutics Announces Completion of..
08/04/202409:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
04/04/202409:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
03/04/202417:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
01/04/202409:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
26/03/202417:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
26/03/202408:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
18/03/202409:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
11/03/202409:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
26/02/202410:00GLOBEBiora Therapeutics Announces Successful Completion of..
08/02/202410:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
22/01/202410:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
16/01/202410:00GLOBEBiora Therapeutics Provides Outlook for 2024
08/01/202410:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
02/01/202410:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
19/12/202310:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
18/12/202310:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
11/12/202310:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
30/11/202320:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
30/11/202319:29DJNBiora Therapeutics Application for Ulcerative Colitis..
30/11/202318:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
13/11/202318:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
06/11/202310:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
30/10/202317:05GLOBEBiora Therapeutics Submits Updated IND Application for..
23/10/202318:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
05/10/202309:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
25/09/202309:00GLOBEBiora Therapeutics Announces Submission of IND Application..
19/09/202309:00GLOBEBiora Therapeutics Reduces Debt and Largest Shareholder..
11/09/202309:01GLOBEBiora Therapeutics to Present at H.C. Wainwright 25th Annual..
05/09/202309:00GLOBEBiora Therapeutics Progresses its BioJet™ Systemic Oral..
14/08/202317:01GLOBEBiora Therapeutics Provides Corporate Update..
03/08/202309:00GLOBEBiora Therapeutics Announces New Patents Covering its..
02/08/202309:00GLOBEBiora Therapeutics to Participate in Canaccord Genuity 43rd..
27/07/202309:00GLOBEBiora Therapeutics Announces Clinical Device Performance..
17/07/202307:00GLOBEBiora Therapeutics to Report Second Quarter 2023 Financial..
05/07/202309:00GLOBEBiora Therapeutics Continues to Monetize Legacy Diagnostics..
28/06/202309:30GLOBEBiora Therapeutics Announces New Patents for its NaviCap™..
26/06/202307:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
14/06/202317:05GLOBEBiora Therapeutics Announces Closing of $8 Million..
13/06/202309:00GLOBEBiora Therapeutics Announces $8 Million Registered Direct..
08/06/202310:00GLOBEBiora Therapeutics to Present Preclinical Data on the..